Sign in

CIK 0001787306 · Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812974255
Phone
805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,318,251
in 11 filings, $2.1M under 10b5-1 plans

Net −$3,318,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Matsuda Masaru −$1.8M See Remarks sold 33% of stake
  2. Curran Terrie −$984K Director sold 63% of stake
  3. Welgus Howard G. −$366K Director sold 29% of stake
  4. Watanabe Todd −$139K See Remarks sold <1% of stake
  5. Burnett Patrick −$76K See Remarks sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Munshi Amit Director Grant or award +5,778 9,799
2026-06-05 Munshi Amit Director Grant or award · Stock Option (right to buy) +16,667 16,667
2026-06-05 Gilbert Halley E Director Grant or award +5,778 27,901
2026-06-05 Gilbert Halley E Director Grant or award · Stock Option (right to buy) +16,667 16,667
2026-06-05 Krishnamohan Neha Director Grant or award +5,778 27,901
2026-06-05 Krishnamohan Neha Director Grant or award · Stock Option (right to buy) +16,667 16,667
2026-05-11 Vairavan Latha SVP Chief Financial Officer Sale 10b5-1 −435 $21.05 $9K 85,978
2026-05-11 Burnett Patrick See Remarks Sale 10b5-1 −222 $21.05 $5K 120,244
2026-05-04 Vairavan Latha SVP Chief Financial Officer Sale 10b5-1 −1,341 $23.61 $32K 86,413
2026-05-04 Watanabe Todd See Remarks Sale 10b5-1 −3,172 $23.61 $75K 720,755
2026-05-04 Matsuda Masaru See Remarks Sale 10b5-1 −7,372 $23.27 $172K 127,573
2026-05-04 Matsuda Masaru See Remarks Sale 10b5-1 −884 $23.61 $21K 126,689
2026-05-04 Burnett Patrick See Remarks Sale 10b5-1 −684 $23.61 $16K 120,466
2026-05-01 Welgus Howard G. Director Sale 10b5-1 −7,144 $22.99 $164K 32,600
2026-04-01 Welgus Howard G. Director Sale 10b5-1 −10,000 $23.88 $239K 39,744
2026-03-02 Leonard Keith R Director Option exercise 10b5-1 +27,052 $8.63 $233K 49,175
2026-03-02 Leonard Keith R Director Option exercise 10b5-1 +12,220 $7.51 $92K 61,395
2026-03-02 Leonard Keith R Director Sale 10b5-1 −39,272 $25.39 $997K 22,123
2026-03-02 Leonard Keith R Director Option exercise · Stock Option (right to buy) 10b5-1 −27,052 0
2026-03-02 Leonard Keith R Director Option exercise · Stock Option (right to buy) 10b5-1 −12,220 0

Page 5 of 13 · 241 trades